KIAA1704, a designation often used in the context of human genetics and proteomics, refers to a protein encoded by a gene identified in large-scale sequencing projects, particularly those originating from the Kazusa DNA Research Institute in Japan. The acronym "KIAA" stands for Kazusa Institute cDNA sequencing project, and the numbers that follow correspond to the specific cDNA clone in their library. Proteins like KIAA1704 are usually characterized by having relatively little information available about their function, structure, or role in the cell when first identified.
The KIAA1704 protein, like many proteins initially identified through these sequencing efforts, is typically subjected to further bioinformatics analysis and experimental studies to elucidate its biological significance. This includes investigating its expression patterns, cellular localization, post-translational modifications, and potential interactions with other proteins. Additionally, researchers may explore the evolutionary conservation of the protein to predict its importance and potential functions.Due to the preliminary nature of the information available for KIAA1704, its functions and interactions are not well-defined, making it a subject of ongoing scientific inquiry. Scientists may use a variety of techniques, such as gene knockdown or overexpression studies, to determine the phenotypic consequences of altering KIAA1704 levels in cells or organisms. Moreover, protein-protein interaction assays could reveal the molecular pathways KIAA1704 may be involved in.
Items 11 to 12 of 12 total
디스플레이 라벨:
| 제품명 | CAS # | 카탈로그 번호 | 수량 | 가격 | 引用 | RATING |
|---|---|---|---|---|---|---|
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
미세소관 중합을 방해하여 세포 주기 및 잠재적으로 FAM208A 관련 경로에 영향을 미칩니다. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $196.00 | 9 | |
광범위한 히스톤 탈아세틸화 효소 억제제는 FAM208A 기능에 영향을 미칠 수 있습니다. | ||||||